Syncope is most common in the young and the old, with an incidence peak at around 15 years of age, particularly in women; subsequently, there is a progressive increase in frequency over the age of ...

Recognising and detecting the signs that commonly precede sudden arrhythmic death syndrome (SADS) may help to prevent premature deaths, according to research presented at ESC Preventive Cardiology ...

Avadel has initiated four patent infringement lawsuits against Jazz Pharmaceuticals since the beginning of 2025, alleging certain uses of Jazz’s Xywav product, according to its corresponding labeling, ...

Is the number of new HIV infections increasing or decreasing worldwide? The number of new HIV infections has declined by 35% globally since 2010; however, new diagnoses have increased among ...

The most common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and postnasal drip (also ...

Sudden arrhythmic death syndrome (SADS) is a stealthy killer of young people, but new research has revealed potential warning ...

He is currently on leave from Nebraska Medicine and remains employed at the ... The defense contends Carlson has vasovagal syncope, a clinical diagnosis for which there is no test.

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

1 Department of Family Medicine, University of Washington, Seattle, Washington, USA 2 Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically ...

Hypotension is low blood pressure. When you have hypotension, the pressure of circulating blood against the walls of your blood vessels is lower than it should be. Blood pressure below 90/60 mm Hg is ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today announced new analyses from its previous Phase 3 program evaluating ampreloxetine, an investigational medicine for the ...